Aphanamixis polystachya (Wall.) Parker.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Synonym | Amoora rohituka W. and A. |
| Family | Meliaceae. |
| Habitat | The sub-Himalayas tracts, Sikkim, Assam, Bengal, western Ghats and the Andamans. |
| Ayurvedic | Rohitaka, Daadimachhada, Daadima-pushpaka, Plihaghna. Tecoma undulata G. Don., Bignoniaceae, is also equated with Rohitaka. |
| Siddha / Tamil | Malampuluvan. |
| Action | Bark—strongly astringent, used in the diseases of the liver and spleen, and for tumours, enlarged glands. Seed oil—used in muscular pains and rheumatism. All parts of the plant exhibit pesticidal activity. Seed extract—antibacterial, antifungal. |
| Taxonomic Cohort | Genus Aphanamixis (1 documented species); Family Meliaceae (16 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Aphanamixis polystachya (taxonomically cited with authority (Wall.) Parker.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Meliaceae (primary family classification: Meliaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy Amoora rohituka W. and A, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: The sub-Himalayas tracts, Sikkim, Assam, Bengal, western Ghats and the Andamans.
Across classical and vernacular Indian systems of medicine, Aphanamixis polystachya is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Rohitaka, Daadimachhada, Daadima-pushpaka, Plihaghna. Tecoma undulata G. Don., Bignoniaceae, is also equated with Rohitaka; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Malampuluvan. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Aphanamixis polystachya are: Bark—strongly astringent, used in the diseases of the liver and spleen, and for tumours, enlarged glands. Seed oil—used in muscular pains and rheumatism. All parts of the plant exhibit pesticidal activity. Seed extract—antibacterial, antifungal. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Aphanamixis polystachya establish the following evidence base: An aqueous extract of the bark, when injected i.p. in normal guinea pigs, showed reduction in absolute lymphocyte count and an increase in spleen weight. The bark appears to be an effective immunosuppressive drug similar to prednisolone. The stembark contains a limonoid, ammorinin and a saponin, poriferasterol-3-rhamnoside.

Botanical Reference 1: Aphanamixis polystachya — Botanical specimen

Botanical Reference 2: Aphanamixis polystachya — Botanical specimen

Botanical Reference 3: Aphanamixis polystachya — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Within Indian medicinal flora, Aphanamixis polystachya stands as a distinct representative of the genus Aphanamixis. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.
At the family level, Meliaceae encompasses 16 documented medicinal species (0.88% of the 1,814-species flora). Other representative medicinal members of Meliaceae include: Aglaia roxburghiana (Priyangu), Amoora cucullata (Amur), Azadirachta indica (Nimba), Cedrela toona (Tuunikaa), Chukrassia tabularis (Bastard Cedar). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 16 medicinal species of family Meliaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Aphanamixis polystachya follow the plant-part modalities specified under its therapeutic action (Bark—strongly astringent, used in the diseases of the liver and spleen, and for tumours, enlarged glands. Seed oil—used in muscular pains and rheumatism. All parts of the plant exhibit pesticidal activity. Seed extract—antibacterial, antifungal), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Aphanamixis polystachya integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.